GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WPD Pharmaceuticals Inc (XCNQ:WBIO) » Definitions » Retained Earnings

WPD Pharmaceuticals (XCNQ:WBIO) Retained Earnings : C$-22.19 Mil (As of Jun. 2024)


View and export this data going back to 2008. Start your Free Trial

What is WPD Pharmaceuticals Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. WPD Pharmaceuticals's retained earnings for the quarter that ended in Jun. 2024 was C$-22.19 Mil.

WPD Pharmaceuticals's quarterly retained earnings declined from Dec. 2023 (C$-22.01 Mil) to Mar. 2024 (C$-22.17 Mil) and declined from Mar. 2024 (C$-22.17 Mil) to Jun. 2024 (C$-22.19 Mil).

WPD Pharmaceuticals's annual retained earnings declined from Dec. 2020 (C$-20.17 Mil) to Dec. 2022 (C$-21.93 Mil) and declined from Dec. 2022 (C$-21.93 Mil) to Dec. 2023 (C$-22.01 Mil).


WPD Pharmaceuticals Retained Earnings Historical Data

The historical data trend for WPD Pharmaceuticals's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WPD Pharmaceuticals Retained Earnings Chart

WPD Pharmaceuticals Annual Data
Trend Jan13 Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Dec20 Dec22 Dec23
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.79 -2.57 -20.17 -21.93 -22.01

WPD Pharmaceuticals Quarterly Data
Apr19 Jul19 Oct19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -22.05 -22.14 -22.01 -22.17 -22.19

WPD Pharmaceuticals Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


WPD Pharmaceuticals  (XCNQ:WBIO) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


WPD Pharmaceuticals Business Description

Traded in Other Exchanges
Address
700-595 Burrard Street, Suite 401, Vancouver, BC, CAN, V7X 1S8
WPD Pharmaceuticals Inc is a biotechnology research and development company. It focuses on oncology, virology, research, and development of medicinal products involving biological compounds and small molecules.
Executives
Constantine Carmichel Director

WPD Pharmaceuticals Headlines

No Headlines